SI Group appoints Frank Yang as VP & managing director

04 Jan 2024
www.medicalplasticsnews.com
Executive Change
SI Group, a global developer and manufacturer of performance additives, process solutions, pharmaceuticals, and chemical intermediates, has announced it has appointed Frank Yang as VP & managing director, Asia Pacific. As the VP & managing director, Asia Pacific, Yang will lead SI Group’s Asia Pacific management team to optimise the business and deliver results in the region. With more than 20 years of experience, Yang brings knowledge from global chemical organisations. Most recently, Yang was the vice president – strategy at INEOS Aromatics. Prior to INEOS Aromatics, Yang held leadership roles on several continents at bp Global Petrochemicals, bp, and PetroChina. “While the Asia Pacific chemical market is currently dynamic, the region continues to be important for SI Group—we’re confident that Frank’s history of successfully growing and transforming businesses will be a tremendous addition to our organisation,” said Joey Gullion, chief commercial officer at SI Group. “With Frank as VP & managing director, Asia Pacific, we look forward to delivering more value to our customers and shareholders in the region now and in the future.” “SI Group has a strong brand and market presence in the region with opportunity for growth and an ambitious vision statement, making it an exciting organisation to join,” said Frank Yang. “I’m eager to advance the business while building on the company’s already strong safety and reliability foundation.” Yang has a master’s degree in business management from the University of Chicago and a degree in chemical engineering from East China University of Science and Technology.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.